HDAC9 and neuroblastoma: Moreover, combined therapy with HDAC inhibitors and ATRA down-regulated c-Myc, the neuronal markers NeuN and β-3 tubulin, as well as the oncoprotein BMI1, and more potently reduced cellular proliferation in NB cell lines (Almeida et al., 2017).